MedTrace Logo

Does Sildenafil Protect Against Pulmonary Related Complications Following Cardiopulmonary Bypass?

NCT00350441 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2006-10-11

No results posted yet for this study

Summary

Does pre-operative administration of Sildenafil (Viagra, Pfizer) reduce the lung injury associated with cardiopulmonary bypass in children undergoing corrective surgical repair of congenital heart disease.

Conditions

  • Cardiopulmonary Bypass

Interventions

DRUG

Sildenafil Citrate

Sponsors & Collaborators

  • NHS Greater Glasgow Yorkhill Division

    lead OTHER

Principal Investigators

  • Tony Vassalos, MB Ch B · Royal Hospital for Sick Children

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Months
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00350441 on ClinicalTrials.gov